23 /100
LOW RISK
Score updated Jul 13, 2026

MIRM — Mirum Pharmaceuticals, Inc. Dilution Risk Tracker

Track MIRM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MIRM — Get alerts when the score changes →

As of July 13, 2026, Mirum Pharmaceuticals, Inc. (MIRM) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. Mirum Pharmaceuticals, Inc. has a market capitalization of $6.19B, 60.98M shares outstanding, 314 institutional holders tracked. Key dilution vectors include 536.4K outstanding warrants, approximately 19 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
26
💰 Cash Runway
25
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
🔁 Convertible Conversion 15%
• Convertible debt present: 5.0% potential dilution
🔔 Track MIRM — Get forecast alerts →

💹 Market Data

Market Cap$6.19B
Shares Outstanding60.98M
Float52.48M
Cash$386.26M
Debt$323.78M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 35.4% shares (2026Q1 vs prior)
314 institutional holders · 83.51M shares
#1 JANUS HENDERSON GROUP PLC 13.74M shares
#2 Frazier Life Sciences Management, L.P. 7.68M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.83M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.48M
Days to Cover5.0
% of Float14.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
4 INSIDER TRANSACTION Apr 16, 2026
8-K/A 8K EVENT Apr 08, 2026
4 INSIDER TRANSACTION Mar 17, 2026
4 INSIDER TRANSACTION Mar 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MIRM Shareholders

Mirum Pharmaceuticals, Inc. (MIRM) has a DilutionScore of 23/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch tracks 536,412 outstanding warrants for MIRM. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for MIRM in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for MIRM alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track MIRM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MIRM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MIRM
📊 MIRM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MIRM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.